Abstract:Objective To explore the fluctuation of cytokine mRNA expression level in a novel T-cell-mediated immune hepatic fibrosis model induced by repeatedly injections of Concanavalin A in BALB/c mice. Methods BALB/c mice were divided into different groups. Model group mice were injected weekly up to 20 weeks with Concanavalin A (15mg/kg), via retro-orbital venous plexus under ether anesthesia. Normal control group mice were treated in the same manner weekly with normal saline. Twenty-four hours after Concanavalin A challenge at 1, 5, 12 and 20 week, 8 mice from each time were killed by cervical dislocation, repectively. The livers of different group were excised and fixed in 10% formalin for HE staining and Gomori Ag staining or frozen in optimal cutting temperature (O.C.T.) media in liquid nitrogen for immunohistochemical staining for CD4 +T or CD8 +T cell. After extracting total RNA from liver tissues, IL-2, IL-4, IL-10 and transforming factor β1 messenger RNA were amplified by reverse transcription polymerase chain reaction. PCR products were electrophoresed on agrose containing ethidium bromide and visualized under ultraviolet light. Densitometric RT-PCR data were standardized with β-actin signals. Results The histological change of HE staining and Gomori Ag staining indicated the fibrogenesis in model group mice. Immunohistochemical staining for CD4 + or CD8 + T cell indicated that the infiltrating lymphocytes in liver parenchyma were mainly CD4 +T lymphocytes. IL-2 mRNA expression level only increased after the first injection of Concanavalin A. The expression levels of IL-4, IL-10 and transforming growth factor β1 mRNA significantly increased over the whole experiment period as compared with control group. Conclusions Repeated administration of Concanavalin A can induce T-cell-mediated immune hepatic fibrosis model in BALB/c mice. The expression levels of IL-4, 10 and TGF-β1 increase over the whole experiment period and may play an important role in creating mouse fibrotic model.

Expressions of activin A and its type Ⅱ A receptor in liver injury of model mice induced by Con A

Concanavalin A induced murine model for hepatic fibrosis

The effect of histone deacetylase inhibitor ACY1215 on the inflammatory response in mice with acute liver failure

Upregulated Expression of Apoptosis-Associated Molecules in ConA-induced Liver Injury

Liver Injury in Mice Induced by ConA

The Fluctuation of Cytokine Mrna Expression Level of a Novel T-cell-mediated Immune Hepatic Fibrosis Model in Balb/c Mice

The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-induced Hepatitis in Mice.

The molecular mechanism of acute liver injury and inflammatory response induced by Concanavalin A

The effect of activin A neutralizing antibody on the expression of eytokines in liver tissue of the mouse

Expression Changes of Activin A in the Process of Hepatic Fibrosis

Expression Changes of Activin A in the Development of Hepatic Fibrosis

The mechanism of how anti-IL-18 prevents concanavalin-A-induced hepatic fibrosis on a mouse model.

The Mechanism of Concanavalin A Induced Liver Injury

EXPRESSION OF ACTIVIN SUBUNITS IN CCl4 INDUCED HEPATIC FIBROSIS IN RATS

Establishment and Morphological Study of a Novel T-cell-mediated Immune Hepatic Fibrosis Model in BALB/C Mice

Expression of Activins, Follistatin Mrna in the Development of Hepatic Fibrosis

Analysis of differential expression of serum proteins in concanavalin A induced liver injury mouse model

The expression of A20 in liver tissue of mice with hepatic fibrosis

Protective Effect of Recombinant Hepatical Stimulator Analogue on Concanavalina A-induced Acute Liver Injury in Mice

A Microarray Analysis of Early Activated Pathways in Concanavalin A-induced Hepatitis

Proteomic Analysis of Differentially Expressed Proteins in Mice with Concanavalin A-induced Hepatitis